Axsome Therapeutics, Inc. today announced that SYMBRAVO® (meloxicam and rizatriptan) is now available by prescription in the United States for the acute treatment of migraine with or without aura in adults. SYMBRAVO represents a novel multi-mechanistic approach to treating migraine that targets multiple brain pathways underlying a migraine attack.
Press release linked in bio.
#migraine #headache #migrainetreatment
https://www.instagram.com/p/DKu3uGnMtrX
Posted on Instagram ·
60
8
60
8
Suggested Credits
Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.